Table 2.
Outcomes.
| Rapid Antigen Test Group (N = 1132) | mPCR Group (N = 149) | p-value | |
|---|---|---|---|
| DOT/case | 12.82 ± 9.62 | 8.56 ± 5.13 | <0.001 |
| LOS (days) | 8.18 ± 9.78 | 6.83 ± 2.03 | 0.032 |
| Total cost (JPY) | ∖258,824 | ∖243,841 | |
| Hospitalization cost | ∖157,776 | ∖142,811 | |
| Social cost | ∖96,683 | ∖80,708 | |
| Cost of the tests | ∖4365 | ∖20,323 | |
| Pathogen detection | 30.2% | 87.2% | <0.001 |
| Treatment failure | 2.6% | 2.0% | 0.661 |
The values are shown as the average value ± standard deviation.
The cost of the mPCR test was calculated according to the reagent cost and device cost per test.
The device cost per test was estimated according to the device cost in the study period divided by the number of tests performed in the study period.
DOT; days of therapy, DPC; diagnosis procedure combination, JPY; Japanese yen, LOS; length of stay.